ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Marc Labelle, 61, died on Jan. 1 in Bedford, New Hampshire.
“Marc was a visionary, charismatic, and talented scientist. He was an inspiration, with his unique approach to chemistry, infectious laugh, and strong zest for life. It was Marc’s creative intuition that led to the discovery of the asthma drug Singulair. After leaving Merck & Co. in 2000, he worked at Amgen, ImClone Systems, and Lundbeck Research USA. In 2011, while running a highly successful consulting business, he became an associate professor at the Université de Sherbrooke. Marc received numerous awards, including the American Chemical Society Heroes of Chemistry Award in 2003. Marc was a coauthor of nearly 100 patents and research articles.”—Tim Cushing, friend and colleague
Most recent title: Owner, ML Pharma Consulting, and associate professor of chemistry, Université de Sherbrooke
Education: BS, chemistry, 1978, and PhD, organic chemistry, 1983, University of Montreal
Survivors: Wife, Helene Perrier; daughter, Evelyne; son, Felix
To recognize your late loved one or colleague, submit obituary information at cenm.ag/obits.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter